Sponsor

NGM Biopharmaceuticals, Inc

Clinical research sponsor

Published trials9

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

9 shown

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid TumorsNCT05311618 · lead sponsor · 2022-05-11

UNKNOWN

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid TumorsNCT05215574 · lead sponsor · 2022-03-31

ACTIVE_NOT_RECRUITING

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesNCT04913337 · lead sponsor · 2021-06-09

UNKNOWN

Study of NGM395 in Adult ParticipantsNCT04187339 · lead sponsor · 2020-02-13

COMPLETED

Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyNCT04068896 · lead sponsor · 2019-10-16

COMPLETED

Study of NGM313 in Obese ParticipantsNCT03298464 · lead sponsor · 2017-09-11

COMPLETED

Phase 1 Study of NGM313 in Healthy Adult ParticipantsNCT02708576 · lead sponsor · 2016-02-01

COMPLETED

Phase 2 Study of NGM282 in Patients With Type 2 DiabetesNCT01943045 · lead sponsor · 2013-09-01

COMPLETED

Phase 1 SAD and MAD Study of NGM282 in Healthy Adult ParticipantsNCT01776528 · lead sponsor · 2013-01-01

COMPLETED

Sponsor roles

lead sponsor9

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.